Selvita prospectus approved

The Financial Supervision Authority has approved the issue prospectus of NewConnect-listed biotechnology firm Selvita, the watchdog said in a statement on Tuesday. Selvita plans to move listing to the main market of the Warsaw Stock Exchange. In connection with the move, it will carry out a public offering of shares. Earlier in November, the company’s CEO told ISBnews that a main market debut would be possible before the end of this year.